Protocatechuic Acid Ethyl Ester Protects Against Doxorubicin-induced Cardiotoxicity in Rats
Drug Research · 01.07.2026 · 76 (04/06) · 131-138
DOI: 10.1055/a-2829-7178 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Research, erschienen am 01.07.2026. Verfasst von Leila Safaeian und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan Universit…. Hauptthemen laut MEDLINE: Doxorubicin, Hydroxybenzoates, Cardiotoxicity.
Abstract (Originalsprache)
Background
Doxorubicin, an anti-neoplastic agent, is linked with a risk of cardiotoxicity following acute or cumulative doses. Protocatechuic acid ethyl ester, as a natural phenolic acid derivative, inhibits a prolyl hydroxylase enzyme with iron-chelating and antioxidative properties. This study evaluated the effects of protocatechuic acid ethyl ester on cardiotoxicity induced by doxorubicin in an animal model.
Methods
Male Wistar rats were pretreated orally with 50, 75, and 150 mg/kg of protocatechuic acid ethyl ester for 14 days. Cardiotoxicity was induced by the acute injection of doxorubicin (20 mg/kg) on the 10th day. Recording of the electrocardiogram, assessment of serum parameters of aspartate aminotransferase, lactate dehydrogenase, creatine phosphokinase-MB, malondialdehyde and total antioxidant capacity as ferric reducing antioxidant power, and histopathological inspection of heart tissues were performed.
Results
Protocatechuic acid ethyl ester at all doses prevented the increase in heart rate and the decrease in the R-R interval induced by doxorubicin. Higher doses of protocatechuic acid ethyl ester (75 and 150 mg/kg) were able to improve most of the serum and tissue parameters of cardiac injury. Protocatechuic acid ethyl ester at a dose of 150 mg/kg significantly reduced lactate dehydrogenase (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran (the Islamic Republic of).
- Department of Pathology, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran (the Islamic Republic of).
- Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran (the Islamic Republic of).
ORCID-Profile: Leila Safaeian
Zitieren
APA
Safaeian, L., Farsiabi, M., Haghighatian, Z., & Asghari-Varzaneh, M. (2026). Protocatechuic Acid Ethyl Ester Protects Against Doxorubicin-induced Cardiotoxicity in Rats. Drug Research, 76(04/06), 131-138. https://doi.org/10.1055/a-2829-7178
Vancouver
Safaeian L, Farsiabi M, Haghighatian Z, Asghari-Varzaneh M. Protocatechuic Acid Ethyl Ester Protects Against Doxorubicin-induced Cardiotoxicity in Rats. Drug Research. 2026;76(04/06):131-138. doi:10.1055/a-2829-7178
BibTeX
@article{Safaeian2026,
author = {Safaeian, Leila and Farsiabi, Maryam and Haghighatian, Zahra and Asghari-Varzaneh, Mansooreh},
title = {Protocatechuic Acid Ethyl Ester Protects Against Doxorubicin-induced Cardiotoxicity in Rats},
journal = {Drug Research},
year = {2026},
volume = {76},
number = {04/06},
pages = {131--138},
doi = {10.1055/a-2829-7178}
}
EUVIMED